AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE)
NCT ID: NCT06728020
Last Updated: 2025-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
200 participants
INTERVENTIONAL
2025-04-30
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Primary Objectives:
-To assess the effects on functional recovery in subacute stroke survivors of a technological rehabilitation station placed at patients' bedsides, combined with dedicated coaching provided to all users (patients, informal caregivers, and formal caregivers).
Secondary Objectives:
* Evaluation of the effects of the experimental treatment on patient satisfaction, upper limb motor skills, manual dexterity, global cognitive functioning, anxiety, and depression.
* Assessment of user experience, acceptance, and usability of the technology by patients and caregivers.
* Evaluation of social impact using the Social Return on Investment (SROI) ratio of the experimental treatment.
Participants randomized into one of the experimental groups, in addition to receiving conventional care, will use the ROOMMATE system during their hospitalization. The system will be made available to patients and will be free for them to use at their discretion.
The station will include:
Multimedia monitors (Khymeia home kit): These will deliver cognitive and motor serious games, educational and rehabilitative content, as well as infotainment specifically developed by the clinical partners of the project.
An inertial sensor kit: This integrates with the monitors to guide users through virtual reality environments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Rehabilitation Early After Stroke Using Feedback-controlled Robotics-assisted Treadmill Exercise
NCT01679600
Rehabilitation Multi Sensory Room for Robot Assisted Functional Movements in Upper-limb Rehabilitation in Chronic Stroke
NCT03208634
Multi-segmental Robotic and Technological Upper Limb Rehabilitation in Stroke
NCT02879279
Reliability of Sensor-Derived Measurements of the SENSorized Fugl-Meyer (FMA) in Subjects with Stroke Outcomes
NCT06893367
Physiotherapy and Action-Observation Therapy: An Integrated Approach for Upper Limb Impairment in Subacute Stroke
NCT04560764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study involves three successive phases:
Phase 1 During the first phase, after obtaining Ethics Committee approval, Living Labs will be planned. In these sessions, end users will test the proposed solutions and provide feedback on acceptability and usability. This phase is critical for defining user and system requirements. Additionally, health professionals will be trained as system coaches to support patients and their families in the subsequent phases.
The coaches will be selected from health professionals (physical therapists, occupational therapists, speech therapists, psychologists, nurses) with at least three professionals per center. They will complete a one-week course in digital literacy (e-literacy), covering:
* Technical and operational skills for managing and using digital technologies.
* Information and navigation skills.
* Specific training on the use of the Khymeia Home Kit.
* Training on using the inertial sensors developed by UNIFI. The training will conclude with a written and practical exam.
Subsequently, a multicenter multiple cohort RCT (cmRCT) will be conducted, consisting of two trials:
1. A first RCT (Phase 2 of the study).
2. A second pilot RCT (Phase 3 of the study). The study will be carried out in an inpatient setting for individuals with subacute stroke outcomes at the two clinical centers: IRCCS Fondazione Don Carlo Gnocchi in Florence, Italy, and Elias University Emergency Hospital in Bucharest, Romania.
The cmRCT design was chosen to address some limitations of traditional RCTs, such as issues with recruitment, ethics, patient preferences, and treatment comparison. Moreover, the cmRCT allows the simultaneous evaluation of different interventions.
In ROOMMATE, eligible patients who consent to baseline (T0) and final (T1, three weeks later) assessments may also be offered an additional intervention, forming the ROOMMATE Study Cohort. A subset of these patients will be randomized to receive an offer to participate in the ROOMMATE Interventions (B or B1), while those not randomized will form the control group (A, receiving usual care). This design will allow two successive RCTs to be conducted.
Phase 2
The first RCT will compare usual care (A) with a preliminary version of the ROOMMATE solution (B), which includes:
* Usual care.
* The Khymeia Home Kit monitor.
* Educational and rehabilitative content developed by clinical partners.
* Coaching for technology use. The sample size for this RCT is 140 patients, randomly assigned to Group A or B, with competitive enrollment across the two clinical centers.
The Khymeia Home Kit, supplemented with educational content, can be used by patients alone or with a caregiver. The educational materials will include:
* General information about stroke pathogenesis and prognosis.
* Strategies and advice for managing the condition.
* Health-related content, such as details on daily hospitalization routines, the roles of various care professionals, and discharge management (including bureaucratic aspects).
* Information on local support networks. Additional cognitive and motor rehabilitation content will be developed by a multidisciplinary team and customized by department therapists to match each patient's needs and recovery potential.
The coach will be available in person five days a week to support all end users in using the ROOMMATE technology.
Phase 3
Following the completion of the first RCT, a second pilot RCT with 60 patients will test usual care (A) against a mature version of the ROOMMATE solution (B1). This includes:
* Usual care.
* Motor and cognitive treatment supported by inertial sensor assessment for personalized interventions.
* Integration of clinical assessments with IMU-derived reports.
* Educational and rehabilitative content developed by clinical partners.
* Coaching for technology use. In Group B1, the Khymeia Home Kit (with educational and rehabilitation content) will be enhanced with inertial sensors developed by UNIFI. These sensors will measure hand motility and provide tailored rehabilitation interventions.
The ROOMMATE intervention will last three weeks per patient. During this period:
* Group B patients will receive training in using the technology from the coach.
* Patients and their families will have self-directed or supervised access to HKK features, including educational, rehabilitative, and infotainment content.
* Therapists will recommend the most appropriate content based on the patient's needs.
* In Group B1, the physician will use inertial sensor data to quantify motor deficits and tailor the treatment accordingly.
Assessments (T0 and T1)
At baseline (T0) and post-treatment (T1), the following will be assessed:
* Demographics: Sex, age, education.
* Clinical data: Type of stroke, time since stroke, lesion laterality.
* Primary and secondary outcomes: Disability in ADLs (modified Barthel Index, mBI). Manual dexterity. Upper limb motor skills. Neuropsychological and global cognitive functioning. Anxiety and depression. Quality of life.
At post-treatment (T1), also the following will be assessed:
• Primary and secondary outcomes: Usability, feasibility, and social impact measures. User experience and education evaluation. Wearability of sensors. Social impact and patient satisfaction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Conventional rehabilitation (Group A)
The first 140 patients who meet the inclusion criteria will be randomized between this group and group B. This group will undergo conventional therapy.
Active Comparator: Conventional rehabilitation (Group A)
The conventional group will undergo standard rehabilitation treatment according to the rehabilitation plan developed by the rehabilitation team. This group will undergo 3 hours of rehabilitation per day and will carry out face-to-face rehabilitation following an impairment-based approach aimed at the treatment of motor-cognitive functions.
ROOMMATE 1st (Group B)
The 70 patients randomized to this group will undergo conventional treatment and, in addition, will have the first version of the ROOMMATE system.
ROOMMATE 1st
In addition to Group A, this group will have the bedside multimedia monitor apparatus to access informative, rehabilitation, and entertainment content. Additionally, this group will have a digital and innovation coach to receive support in using the technology.
ROOMMATE 2nd (Goup B2)
Group B2 will undergo conventional treatment and will have an extended version of the bedside multimedia monitor apparatus, integrated with an inertial sensor to enable the serious games on the experimental platform.
ROOMMATE 2nd
Once the first RCT of the cmRCT is completed, a pilot RCT will be initiated, randomizing 60 cases between Group A and this group. In addition to conventional treatment, this group will have a version of the ROOMMATE system integrated with inertial sensors worn on the hands and fingers to guide the serious games on the platform.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active Comparator: Conventional rehabilitation (Group A)
The conventional group will undergo standard rehabilitation treatment according to the rehabilitation plan developed by the rehabilitation team. This group will undergo 3 hours of rehabilitation per day and will carry out face-to-face rehabilitation following an impairment-based approach aimed at the treatment of motor-cognitive functions.
ROOMMATE 1st
In addition to Group A, this group will have the bedside multimedia monitor apparatus to access informative, rehabilitation, and entertainment content. Additionally, this group will have a digital and innovation coach to receive support in using the technology.
ROOMMATE 2nd
Once the first RCT of the cmRCT is completed, a pilot RCT will be initiated, randomizing 60 cases between Group A and this group. In addition to conventional treatment, this group will have a version of the ROOMMATE system integrated with inertial sensors worn on the hands and fingers to guide the serious games on the platform.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willingness to participate in the project, with informed consent signed by the subject or, when necessary, by the support administrator.
Exclusion Criteria
* severe cognitive and/or speech impairments that interfere with the ability to use the HKK system and the SensoMode accessory independently and/or in the
* absence of a caregiver who can assist the patient in using the system;
* skin lesions that prevent wearing the inertial sensors;
* presence of signs of clinical instability, defined by a score greater than zero on the Clinical Instability Scale (SIC).
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MEDEA, Italy
UNKNOWN
Carol Davila University of Medicine and Pharmacy
OTHER
Roessingh Research and Development
OTHER
University of Florence
OTHER
Francesca Cecchi
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Francesca Cecchi
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Fondazione Don Carlo Gnocchi Onlus
Florence, Florence, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Doronzio S, Jansen-Kosterink S, Tesi M, Castagnoli C, Pedrini C, Ciapetti T, De Marco M, Piazzini M, Giacani J, Ciobanu I, Berteanu M, Fiorini L, Rovini E, Cavallo F, Agnoloni F, Baccini M, Cecchi F. Development of a cohort multiple randomized clinical trial to test an integrated system of sensors and multimedia monitors technology, for stroke rehabilitation: the ROOMMATE study protocol. Front Neurol. 2025 Oct 14;16:1568728. doi: 10.3389/fneur.2025.1568728. eCollection 2025.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Grant Agreement Nº: 101095654.
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
cmRCT ROOMMATE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.